---
title: "601089.SH (601089.SH) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/601089.SH/news.md"
symbol: "601089.SH"
name: "601089.SH"
parent: "https://longbridge.com/zh-CN/quote/601089.SH.md"
datetime: "2026-03-12T19:24:05.795Z"
locales:
  - [en](https://longbridge.com/en/quote/601089.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/601089.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/601089.SH/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/601089.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/601089.SH/news.md)


# 601089.SH (601089.SH) — 相关新闻

### [Intraday News - Sanfu Chemical (4755) surged 3.81% to NT$149.0, with a trading volume of 404 shares](https://longbridge.com/zh-CN/news/278016180.md)
*2026-03-06T02:19:34.000Z*
> Sanfu Chemical (4755-TW) stock price rose 3.81% at 10:19 on the 6th, reporting NT$149.0, with a trading volume of 404 sh

### [Foyou Pharma received the approval notice for the listing application of Elamipretide chemical raw materials](https://longbridge.com/zh-CN/news/277428100.md)
*2026-03-02T08:21:02.000Z*
> Foyou Pharma recently received the notice of approval for the marketing application of the chemical raw material drug El

### [Foyou Pharma participates in the continuation procurement of drugs after the expiration of the national organized procurement agreement, intending to be selected](https://longbridge.com/zh-CN/news/275569059.md)
*2026-02-11T07:57:04.000Z*
> Foyou Pharma will participate in the national organized procurement of drugs upon the expiration of the agreement on Feb

### [Foyou Pharma: The hydrochloride bromhexine oral solution has obtained a drug registration certificate](https://longbridge.com/zh-CN/news/275420985.md)
*2026-02-10T07:57:04.000Z*
> Foyou Pharma announced that its wholly-owned subsidiary Foyou Pharmaceutical Co., Ltd. has obtained the drug registratio

### [Foyou Pharma: The hydrochloride quetiapine tablets have obtained the drug registration certificate](https://longbridge.com/zh-CN/news/273492969.md)
*2026-01-23T09:19:53.000Z*
> On January 23rd, Foyou Pharma announced that the National Medical Products Administration issued the Drug Registration C

### [Foyou Pharma: Subsidiary tablet production line passes GMP compliance inspection](https://longbridge.com/zh-CN/news/272669630.md)
*2026-01-15T08:56:32.000Z*
> Foyou Pharma announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical's tablet production line passed 

### [Foyou Pharma: The application for the listing of the raw material drug Piwi Bromide has been approved](https://longbridge.com/zh-CN/news/272515477.md)
*2026-01-14T07:44:03.000Z*
> Foyou Pharma recently received approval from the National Medical Products Administration and successfully applied for t